Abstract
CD59 is the single regulator of the terminal complement pathway. It has been implicated in disease such as Paroxysmal nocturnal hemoglobinuria (PMH) and cancer. Expression of CD59 protects normal and malignant cells from the cytotoxic potential of the complement system. Here we describe a method, which allows for studying its expression on the surface of cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sugita Y, Nakano Y, Oda E et al (1993) Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositol-anchored membrane protein. J Biochem 114:473–477
Cole DS, Hughes TR, Gasque P et al (2006) Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol Immunol 43:1953–1964
Meri S, Vakeva A, Laari T, Lachmann PJ (1991) Soluble forms of CD59-antigen: distribution in body fluids and functional activity. Complement Inflammat 8:193
Bodian D, Davis S, Morgan B et al (1997) Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J Exp Med 185:507–516
Meri S, Morgan B, Davies A et al (1990) Human protectin (CD59), an 18,000–20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71:1–9
Longhi M, Sivasankar B, Omidvar N et al (2005) Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner. J Immunol 175:7098–7102
Sivasankar B, Longhi M, Gallagher K et al (2009) CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy? J Immunol 182:5203–5207
Longhi M, Harris C, Morgan B et al (2006) Holding T cells in check – a new role for complement regulators? Trends Immunol 27: 102–108
Heeger PS, Kemper C (2011) Novel roles of complement in T effector cell regulation. Immunobiology 217(2):216–224
Kimberley FC, Sivasankar B, Paul MB (2007) Alternative roles for CD59. Mol Immunol 44:73–81
Gorter A, Blok VT, Haasnoot WH et al (1996) Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Lab Invest 74:1039–1049
Pierzchalski A, Mittag A, Tárnok A (2011) Introduction A: recent advances in cytometry instrumentation, probes, and methods – review. Methods Cell Biol 102:1–21
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Kolev, M. (2014). Detection of CD59 Using Flow Cytometry. In: Gadjeva, M. (eds) The Complement System. Methods in Molecular Biology, vol 1100. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-724-2_28
Download citation
DOI: https://doi.org/10.1007/978-1-62703-724-2_28
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-723-5
Online ISBN: 978-1-62703-724-2
eBook Packages: Springer Protocols